Distribution of somatostatin receptor messenger RNAs in the rat gastrointestinal tract

Gastroenterology
K KrempelsE Mezey

Abstract

The gastrointestinal (GI) tract is a major source and target of somatostatin (SRIF). Recently, five pharmacologically different SRIF receptors (sst1-5) were cloned. The cellular and tissue distribution of the sst1-5 messenger RNAs (mRNAs) were studied in the rat GI tract using in situ hybridization histochemistry (ISHH). Two sets of (35)S-uridine triphosphate (UTP)-labeled antisense and sense riboprobes were prepared for each sst. ISHH was conducted on frozen tissue samples from rat stomach, duodenum, jejunum, ileum, colon, and pancreas. mRNAs of all five sst-s are widely expressed in the rat GI tract. The distribution pattern for each sst mRNA was identical with both antisense probes. No specific signal was found with any of the sense probes. Each layer of the different parts of the gut expressed mRNAs of multiple sst subtypes. All organs expressed sst3 mRNA very intensely. The lowest levels of mRNA expression for all five subtypes within the GI tract were found in the pancreas. The widespread expression of sst mRNAs suggests a significant role for SRIF in the regulation of GI function.

Citations

Sep 2, 2009·European Journal of Nuclear Medicine and Molecular Imaging·Erik VegtOtto C Boerman
May 2, 2009·American Journal of Physiology. Gastrointestinal and Liver Physiology·M D Perry, G I Sandle
Apr 15, 2003·The Journal of Physiology·Laura PiquerasVicente Martínez
Mar 17, 2004·British Journal of Pharmacology·Laura PiquerasVicente Martínez
Jun 27, 2007·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·J Van Op den BoschJ-P Timmermans
Feb 21, 2006·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·V D CorletoG Delle Fave
Jan 10, 2008·International Journal of Cancer. Journal International Du Cancer·Genady KostenichArie Orenstein
Jan 16, 1999·The Journal of Surgical Research·J S Thompson
Nov 26, 2010·Biochemical and Biophysical Research Communications·Eiichi OgawaNobuya Inagaki
Jul 13, 2012·Metabolism: Clinical and Experimental·Antonello E RigamontiAngela I Pincelli
Aug 6, 1999·Frontiers in Neuroendocrinology·Y C Patel
Mar 23, 2000·Brain Research·J A ClarkT I Bonner
Jul 30, 2002·Molecular Endocrinology·José L RamírezYogesh C Patel
Nov 2, 2019·Physiological Reviews·Amy C EngevikJames R Goldenring
Apr 12, 2003·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·F De JongeJ-P Timmermans
Apr 5, 2003·American Journal of Physiology. Cell Physiology·Ai-Yu GongNicholas F LaRusso
May 4, 2000·American Journal of Physiology. Cell Physiology·A ZólyomiT Balla
Dec 16, 2004·Naunyn-Schmiedeberg's Archives of Pharmacology·Laura Piqueras, Vicente Martínez
Jul 17, 1999·The American Journal of Physiology·V D CorletoR T Jensen
Jul 12, 2002·American Journal of Physiology. Endocrinology and Metabolism·Connie Chisholm, Gordon R Greenberg
Mar 19, 2002·American Journal of Physiology. Gastrointestinal and Liver Physiology·Faiza AbduDavid Grundy
Oct 29, 2000·American Journal of Physiology. Gastrointestinal and Liver Physiology·C Chisholm, G R Greenberg
Sep 13, 2019·International Journal of Molecular Sciences·Slawomir Gonkowski, Liliana Rytel
Nov 23, 2000·Journal of Physiology, Paris·H Baumeister, W Meyerhof
Nov 23, 2000·Journal of Physiology, Paris·S L Cole, M Schindler
Jun 1, 2000·Regulatory Peptides·I SelmerP C Emson
Aug 25, 2001·Journal of Medicinal Chemistry·L PoitoutC Thurieau

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.